ACE Pharmaceuticals has sold a majority stake to private investors and Quadrum Capital
October 2017 — The shareholders of ACE Pharmaceuticals have sold a majority stake in the company to private investors and Quadrum Capital, a Dutch private equity firm.
ACE Pharmaceuticals is a specialized company operating in the niche of medical need products which provide mainly small patient groups or specific indications. Through new, innovative products or by the revitalization of orphaned drugs, the company is able to ensure that these medical need products are or remain available. The company develops and distributes locally and abroad both licensed and non-licensed products. ACE Pharmaceuticals was founded more than 25 years ago as a producer of veterinary medicines. In the early 2000s, the company shifted its focus to human medical need products. Since then, it has experienced strong sales growth and has built an exciting product range and promising product pipeline.
Our role in the transaction
Oaklins's team in the Netherlands acted as M&A advisor to the shareholders of ACE Pharmaceuticals in this transaction.
Talk to the deal team
Sander van 't Spijker
Oaklins Netherlands
Related deals
Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Learn moreHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Learn moreGP-Connect has joined forces with Transformation Capital to accelerate growth
Transformation Capital, a Netherlands-based investment firm, has joined forces with GP-Connect, a leading international secondment platform with specialized brands serving the hospitality, IT, skilled labor, technical services and dental sectors. As part of the transaction, GP-Connect welcomes Transformation Capital as its new shareholder to support the company’s next phase of growth, while the founders and existing shareholders will remain actively involved. The partnership will focus on executing a targeted buy-and-build strategy, expanding the business internationally and further strengthening GP-Connect’s portfolio.
Learn more